Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Lee A ymar Ndounga Diakou"'
Autor:
Lee A ymar Ndounga Diakou, Isabelle Boutron, Asbjørn Hróbjartsson, Philippe Ravaud, Amélie Yavchitz, Caroline Barnes, Ludovic Trinquart
Publikováno v:
The Cochrane Library
Cochrane Database Syst Rev
Ndounga Diakou, L A Y, Trinquart, L, Hróbjartsson, A, Barnes, C, Yavchitz, A, Ravaud, P & Boutron, I 2016, ' Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates ', Cochrane Database of Systematic Reviews, vol. 2016, no. 3, MR000043 . https://doi.org/10.1002/14651858.MR000043.pub2
Cochrane Database Syst Rev
Ndounga Diakou, L A Y, Trinquart, L, Hróbjartsson, A, Barnes, C, Yavchitz, A, Ravaud, P & Boutron, I 2016, ' Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates ', Cochrane Database of Systematic Reviews, vol. 2016, no. 3, MR000043 . https://doi.org/10.1002/14651858.MR000043.pub2
BACKGROUND: Assessment of events by adjudication committees (ACs) is recommended in multicentre randomised controlled trials (RCTs). However, its usefulness has been questioned.OBJECTIVES: The aim of this systematic review was to compare 1) treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20eb2bd1471a05ff22423664e811e480
https://doi.org/10.1002/14651858.mr000043.pub2
https://doi.org/10.1002/14651858.mr000043.pub2
Autor:
Felix Koukouikila-Koussounda, Pembe Issamou Mayengue, Francine Ntoumi, Brunelle Diassivy Matondo, Prisca Nadine Casimiro, Mathieu Ndounga, Lee A ymar Ndounga Diakou, Leonardo K. Basco, Michel Bitemo
Publikováno v:
Malaria Journal
Malaria Journal, BioMed Central, 2015, ⟨10.1186/s12936-015-0918-6⟩
Malaria Journal, 2015, ⟨10.1186/s12936-015-0918-6⟩
Malaria Journal, BioMed Central, 2015, ⟨10.1186/s12936-015-0918-6⟩
Malaria Journal, 2015, ⟨10.1186/s12936-015-0918-6⟩
Background The Republic of Congo adopted a new anti-malarial treatment policy in 2006, with artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) as the first- and second-line anti-malarial drugs, respectively. Only three clinical studies ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1d2749e56eb267e2a6d1b0bfc1ecf6d
https://hal.archives-ouvertes.fr/hal-01284955
https://hal.archives-ouvertes.fr/hal-01284955
